Impact of Remote Care in Patients Diagnosed With Thromboembolic Disease of Low Risk (TEVEDOM)
Thromboembolic Disease
About this trial
This is an interventional other trial for Thromboembolic Disease
Eligibility Criteria
Inclusion Criteria: patients identified in the emergency department with a thromboembolic disease, with a deep vein thrombosis or pulmonary embolism with a low risk of mortality according to recommendations affiliated or beneficiary of social protection Exclusion Criteria: patient having a severe obstruction syndrome, a thromboembolic disease already under treatment or a suspicion of thrombocytopenia induced by heparin patient with an active hemorrhage or a major risk of hemorrhage, a renal severe failure, comorbidities such as cancer, or the impossibility to organise a consultation or a patient in a non favorable medico-social context patient with a caval thrombosis patient suffering of a disease at hemorrhagic risk or neurosurgery intervention done in the last month or other surgery in the last 15 days prior to inclusion patient with contraindication of direct oral anticoagulants, such as bitherapy with antiplatelet agent, imidazoles, macrolides, antiretroviral treatments or an anti-phospholipid syndrome patient that lives in an area not covered by internet patient that has no primary care physician patient not able to understand the study (language, psychological problem) or not able to read or write patient under legal protection
Sites / Locations
Arms of the Study
Arm 1
Experimental
4G Tablet